Skip to main content Accessibility help
×
Home

Cytochromes and Psychotropic Drug Interactions

  • David Taylor (a1) and Malcolm Lader (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cytochromes and Psychotropic Drug Interactions
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cytochromes and Psychotropic Drug Interactions
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cytochromes and Psychotropic Drug Interactions
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

Professor M. Lader, Maudsley Hospital, Denmark Hill, London SE5 8AF. Fax: 0171 919 2171

References

Hide All
Alderman, J., Greenblatt, D. J., Allison, J., et al (1994) Desipramine pharmacokinetics with the serotonin reuptake inhibitors, paroxetine or sertraline. Data on File. Sandwich, Kent: Pfizer.
Barros, J. & Asnis, G. (1993) An interaction of sertraline and desipramine. American Journal of Psychiatry, 150, 1751.
Brøsen, K., Skjelbo, E., Rasmussen, B. B., et al (1993) Fluvoxamine is a potent inhibitor of cytochrome P450–1A2. Biochemical Pharmacology, 45, 12111214.
Centorrino, F., Baldessarini, R.J., Kando, J., et al (1994) Serum concentrations of clozapine and its major metabolites: effects of co-treatment with fluoxetine or valproate. American Journal of Psychiatry, 151, 123125.
Cholerton, S., Daly, A. K. & Idle, J. R. (1992) The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends in Pharmacological Science, 13, 434439.
Crewe, H. K., Lennard, M. S., Tucker, G. T., et al (1992) The effect of selective serotonin re-uptake inhibitors on cytochrome P450 2D6 (CYP2D6) activity in human liver microsomes. British Journal of Clinical Pharmacology, 34, 262265.
Fischer, V., Vogels, B., Maurer, G., et al (1992) The antipsychotic clozapine is metabolised by the polymorphic human microsomal and recombinant cytochrome P450 2D6. Journal of Pharmacology and Experimental Therapeutics, 260, 13551360.
Gascon, M.-P. & Dayer, P. (1991) In vitro forecasting of drugs which may interfere with the biotransformation of midazolam. European Journal of Clinical Pharmacology, 41, 573578.
Gorski, J. C., Hall, S. D., Jones, D. R., et al (1994) Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP 3A) subfamily. Biochemical Pharmacology, 47, 16431653.
Gram, L. F., Hansen, M. G. J., Sindrup, S. H., et al (1993) Citalopram: Interaction studies with levomepromazine, imipramine, and lithium. Therapeutic Drug Monitoring, 15, 1824.
Guengerich, F. P. (1992) Human cytochrome P-450 enzymes. Life Sciences, 50, 14711478.
Hahn, S. M. & Griffin, J. H. (1991) Comment: fluoxetine adverse effects of drug interactions. DICP – Annals of Pharmacotherapy, 25, 12731274.
Hartter, S. H., Wetzel, H., Hammes, E., et al (1993) Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients. Psychopharmacology, 110, 302308.
Horton, R. C. & Bonser, R. S. (1995) Interaction between cyclosporin and fluoxetine. British Medical Journal, 311, 422.
Ketai, R. (1993) Interaction between fluoxetine and neuroleptics. American Journal of Psychiatry, 150, 836837.
Kronbach, T., Mathys, D., Umeno, M., et al (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450 IIIA4. Molecular Pharmacology, 36, 8996.
Lasher, T. A., Fleishaker, J. C., Steenwijk, R. C., et al (1991) Pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine. Psychopharmacology, 104, 323327.
Marchiando, R. J. & Cook, M. D. (1995) Probable terfenadine-fluoxetine-associated cardiac toxicity. Annals of Pharmacotherapy, 29, 937938.
Maskall, D. D. & Lam, R. W. (1993) Increased plasma concentration of imipramine following augmentation with fluvoxamine. American Journal of Psychiatry, 150, 1566.
Murray, M. (1992) P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clinical Pharmacokinetics, 23, 132146.
Preskorn, S. H., Beber, J. H., Faul, J. C., et al (1990) Serious adverse effects of combining fluoxetine and tricyclic antidepressants. American Journal of Psychiatry, 147, 532.
Preskorn, S. H., Alderman, J., Chung, M., et al (1994) Pharmacokinetics of desipramine co-administered with sertraline or fluoxetine. Journal of Clinical Psychopharmacology, 14, 9098.
Preskorn, S. H., & Magnus, R. D. (1994) Inhibition of hepatic P-450 isoenzymes by selective serotonin reuptake inhibitors: In vitro and in vivo findings and their implications for patient care. Psychopharmacology Bulletin, 30, 251259.
Rasmussen, B. B., Maenpaa, J., Pelkonen, O., et al (1995) Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. British Journal of Clinical Pharmacology, 39, 151159.
Simpson, G. M. & Cooper, T. A. (1978) Clozapine plasma levels and convulsions. American Journal of Psychiatry, 135, 99100.
Slaughter, R. L. & Edwards, D. J. (1995) Recent advances: The cytochrome P450 enzymes. Annals of Pharmacotherapy, 29, 619624.
Thomson, A. H., McGovern, E. M., Bennie, P., et al (1992) Interaction between fluvoxamine and theophylline. Pharmaceutical Journal, 249, 137.
von Moltke, L. L., Greenblatt, D. J., Harmatz, J. S., et al (1993) Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes. Pharmacology, 47, 268276.
von Moltke, L. L., Greenblatt, D. J., Harmatz, J. S., et al (1994) Cytochromes in psychopharmacology. Journal of Clinical Psychopharmacology, 14, 12.
Watkins, P. B. (1990) Role of cytochromes P450 in drug metabolism and hepatotoxicity. Seminars in Liver Disease, 10, 235250.

Cytochromes and Psychotropic Drug Interactions

  • David Taylor (a1) and Malcolm Lader (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Cytochromes and Psychotropic Drug Interactions

  • David Taylor (a1) and Malcolm Lader (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *